Avalanche Biotechnologies Inc Stock Nasdaq
Equities
US05337G1076
Biotechnology & Medical Research
Sales 2024 * | 314K 430K | Sales 2025 * | 8.87M 12.14M | Capitalization | 216M 296M |
---|---|---|---|---|---|
Net income 2024 * | -115M -157M | Net income 2025 * | -140M -192M | EV / Sales 2024 * | 216 x |
Net cash position 2024 * | 149M 204M | Net cash position 2025 * | 136M 185M | EV / Sales 2025 * | 9.13 x |
P/E ratio 2024 * |
-1.9
x | P/E ratio 2025 * |
-1.94
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.65% |
Latest transcript on Avalanche Biotechnologies Inc
Managers | Title | Age | Since |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 22-12-11 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 20-04-15 | |
Clarence Machado
CHM | Chairman | 60 | 17-03-13 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |